Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FyMed Demonstrates Superiority of FY101C over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
CP Wire
Monday, July 23, 2012 - 10:16pm
tags:
FY101C, fymed, painkillers, NSAIDs, chronic pain
Celgene Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, July 23, 2012 - 10:13pm
tags:
earnings, Celgene
Zogenix estimates 2nd-quarter revenue below Street
Reuters
Monday, July 23, 2012 - 10:11pm
tags:
earnings, Zogenix
What Does Wall Street See for Merck's Q2?
Motley Fool
Monday, July 23, 2012 - 10:09pm
tags:
Merck, earnings
Horizon Pharma Moving Ahead Of FDA Decision
Seeking Alpha
Monday, July 23, 2012 - 10:07pm
tags:
FDA, Horizon Pharma, rheumatoid arthritis, Rayos
Italy May Lose Thousands Of Drug-Firm Jobs, Industry Lobby Says
Bloomberg
Monday, July 23, 2012 - 10:04pm
tags:
Italy
Bristol-Myers Squibb Second Quarter Earnings Preview
Investopedia
Monday, July 23, 2012 - 10:02pm
tags:
earnings, Bristol-Myers Squibb
Pfizer's Lyrica does not hurt sperm in study
Reuters
Monday, July 23, 2012 - 10:00pm
tags:
Pfizer, Lyrica
Pfizer, J&J, Elan Alzheimer's Drug Fails
TheStreet.com
Monday, July 23, 2012 - 9:58pm
tags:
Pfizer, JNJ, Elan, Alzheimer's disease, bapineuzumab
Eli Lilly’s Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, July 23, 2012 - 10:19am
tags:
Eli Lilly, earnings
Pfizer Loses Prempro Ruling, Must Pay $10.4 Million
Bloomberg
Monday, July 23, 2012 - 9:25am
tags:
Pfizer, Prempro
Illumina countersues Intelligent Bio-Systems and Qiagen
Reuters
Monday, July 23, 2012 - 9:21am
tags:
Qiagen, Intelligent Bio-Systems, Illumina, patents
Novartis Sandoz unit completes Fougera purchase
Yahoo/AP
Monday, July 23, 2012 - 9:18am
tags:
Sandoz, Novartis, Fougera, M&A
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Monday, July 23, 2012 - 9:15am
tags:
drug approvals, earnings, Amylin, InterMune, Human Genome Sciences, GSK, Bristol-Myers Squibb, Questcor, BiogenIdec, Alexion, Regeneron, Eli Lilly, Amarin, Horizon Pharma, Celgene, Amgen, Gilead, Alkermes, United Therapeutics, Roche, Sanofi, Merck, AstraZeneca, Salix, Progenics Pharmaceuticals
Questcor Pharmaceuticals Is A Buy Before Earnings
Seeking Alpha
Monday, July 23, 2012 - 9:06am
tags:
Questcor Pharmaceuticals, earnings
Pharma IPOs Are Good Medicine
TheStreet.com
Monday, July 23, 2012 - 9:05am
tags:
IPOs, Clovis Oncology, Supernus Pharmaceuticals, NewLink Genetics, Horizon Pharma, Globus Medical, Hyperion Therapeutics
InterMune: Weak Esbriet Sales But In-Line Pricing
TheStreet.com
Monday, July 23, 2012 - 9:01am
tags:
earnings, InterMune
BrainStorm Cell reports outstanding ALS interim clinical trial results
The Fly on the Wall
Monday, July 23, 2012 - 9:00am
tags:
BrainStorm Cell Therapeutics, ALS, NurOwn
3 Pharma Companies Expected To Demonstrate Significant Growth During The Second Quarter
Seeking Alpha
Monday, July 23, 2012 - 8:58am
tags:
BioDelivery Sciences, Spectrum Pharmaceuticals, Questcor
ImmunoCellular Therapeutics: Explaining The Benefits Of A Multiple Antigen Targeting Approach
Seeking Alpha
Monday, July 23, 2012 - 8:56am
tags:
ImmunoCellular Therapeutics, glioblastoma, ICT-107

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.